FRANCESCO TOVOLI

Assistant Professor

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Francesco Tovoli is an Assistant Professor at the University of Bologna, Italy. His research focuses on topics such as osteoporosis screening in celiac disease, occupational toxicants in liver diseases, and advancements in immunotherapy for hepatocellular carcinoma. Recent publications highlight his work on biomarkers for treatment resistance and the interplay between metabolic liver diseases and bone health.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (14)

Ryszard Slomski

Institute of Human Genetics

POLAND

View details

Agnieszka Dobrowolska

Poznan University of Medical Sciences

POLAND

View details

Matteo Renzulli

University of Bologna

ITALY

View details

Carlos López López

Universidad de Cantabria

SPAIN

View details

MARIA LETIZIA PETRONI

Associate Professor

University of Bologna

ITALY

View details

RICCARDO ANTONIO LENCIONI

University of Pisa

ITALY

View details

Emilio Francesco Giunta

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

Fabio Gelsomino

ITALY

View details

Franco Trevisani

University of Bologna

ITALY

View details

Fabio Piscaglia

University of Bologna

ITALY

View details

Laura Gramantieri

University of Bologna

ITALY

View details

Anna Maria Rychter

Poznan University of Medical Sciences

POLAND

View details

Caterina Soldà

Istituto Oncologico Veneto

ITALY

View details

Francesca Fornari

University of Bologna

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

FRANCESCO TOVOLI

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASE

Occupational toxicants in MASLD: Bias, complexity, and future directions

Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma

Advancements in immunotherapy for hepatocellular carcinoma

Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

Exploring Total Immunoglobulin A’s Impact on Non-Biopsy Diagnosis of Celiac Disease: Implications for Diagnostic Accuracy

RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib

Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study

Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

TKIs in combination with immunotherapy for hepatocellular carcinoma

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis

A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival

COVID-19: Has the Liver Been Spared?

Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study

Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact

Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?

Collaborators (14)

Ryszard Slomski

Agnieszka Dobrowolska

Matteo Renzulli

Carlos López López

MARIA LETIZIA PETRONI

RICCARDO ANTONIO LENCIONI

Emilio Francesco Giunta

Fabio Gelsomino

Franco Trevisani

Fabio Piscaglia

Laura Gramantieri

Anna Maria Rychter

Caterina Soldà

Francesca Fornari

Make your next move.